Hereditary Cancer Panel
A germline NGS-based genetic test that identifies inherited variants in cancer predisposition genes, including BRCA1, BRCA2, and extended hereditary panels, enabling early risk assessment and truly personalized preventive care planning today.
Clinical Insight
Hereditary Risk Testing
The Hereditary Cancer Panel is a germline genetic test that examines DNA from a peripheral blood sample to identify inherited variants in genes associated with cancer predisposition. Unlike tumor-based testing, this assay looks at a person's baseline genetic makeup, revealing whether they carry mutations that raise lifetime cancer risk before disease ever develops.
Panel options range from focused testing of BRCA1 and BRCA2 to an extended 11-gene HBOC panel, with customizable panels available based on individual clinical need. Results support early risk identification for conditions such as hereditary breast and ovarian cancer, Lynch syndrome, and familial colorectal cancer, enabling informed decisions around genetic counseling, screening, and preventive care.
Clinical Applications
Identifies inherited BRCA1, BRCA2, and related gene mutations linked to increased lifetime risk of breast and ovarian cancer development.
Clinical Applications
Detects inherited mismatch repair gene mutations associated with Lynch syndrome, a condition raising risk for colorectal and other cancers.
Screens for inherited gene variants linked to familial colorectal cancer, supporting early risk identification within affected families.
Evaluates additional cancer predisposition genes associated with rare or less common hereditary cancer syndromes beyond the primary panels.
Testing Benefits
Know Your Risk Protect Your Future
Early Risk Identification
Detects inherited cancer-predisposing mutations before disease develops, allowing individuals to understand their genetic risk well in advance.
Actionable Biomarker Detection
Provides clear genetic findings that guide meaningful conversations with genetic counselors about risk, family planning, and next steps.
Personalized Surveillance
Informs individualized screening schedules and preventive strategies based on a person's specific inherited cancer risk profile.
Customizable Panel Options
Offers testing ranging from focused BRCA1/BRCA2 analysis to extended multi-gene panels, tailored to individual clinical needs.
Simple Blood-Based Testing
Requires only a peripheral blood sample, making the test accessible and straightforward to incorporate into routine care.
Informs Family Risk Awareness
Identifies hereditary mutations that may also be relevant to blood relatives, supporting broader family risk understanding.
Schedule Your Test
Reach out to our specialists to arrange hereditary cancer testing and receive dedicated support at every step.
